Showing 1,447 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Access to healthcare

New study confirms MPP licences save money and lives

Editor's pick
Medicines Patent Pool
26 October 2021
PrEP policies & guidelines

Gilead Announces Decision Not to Pursue Marketing Authorization for Descovy® for Pre-Exposure Prophylaxis in the European Union

Editor's pick
Gilead press release
22 October 2021
Access to healthcare

2021 HIV Market Report: The state of the HIV market in low- and middle-income countries

Editor's pick
Clinton Health Access Initiative
12 October 2021
HIV treatment for children & young people

ViiV Healthcare submits FDA application for first dispersible single tablet regimen containing dolutegravir (DTG) for children living with HIV

Editor's pick
ViiV Healthcare press release
5 October 2021
Injectable & long-acting HIV treatment

Shionogi licenses out 3rd-gen HIV asset to ViiV

Editor's pick
FierceBiotech
28 September 2021
Injectable & long-acting PrEP

FDA grants Priority Review to ViiV Healthcare’s New Drug Application for cabotegravir long-acting for prevention of HIV

Editor's pick
ViiV Healthcare press release
28 September 2021
Pharmaceutical industry

Gilead, Merck and others slapped with 'pay-for-delay' lawsuits over lucrative HIV and cholesterol meds

Editor's pick
FiercePharma
27 September 2021
HIV treatment for children & young people

Unitaid, the Clinton Health Access Initiative, and Laurus Labs announce agreement to accelerate development of best-in-class second- and third-line HIV medication for children

Editor's pick
Clinton Health Access Initiative
13 September 2021
Access to healthcare

HIV treatment dolutegravir arrives in more upper-middle-income countries

Editor's pick
Medicines Patent Pool
3 September 2021
New & experimental HIV treatments

CytoDyn’s previous HIV filing snafu now on better course after FDA sets them straight

Editor's pick
Fierce Biotech
16 August 2021
Pharmaceutical industry

Negative innovation: when patents are bad for patients

Editor's pick
Nature
12 August 2021
Access to healthcare

Pricing agreement brings HIV drug darunavir within reach of LMICs

Editor's pick
Devex
29 July 2021
Access to healthcare

Innovative agreement launches affordable, optimal second-line HIV treatment in low- and middle-income countries

Editor's pick
Clinton Health Access Initiative
28 July 2021
Access to healthcare

HIV: Breakthrough in cryptococcal meningitis gives Gilead opportunity to fulfil promise to scale up access to key drug

Editor's pick
MSF
22 July 2021
Access to healthcare

Advocates Are Unhappy with the Global AIDS Agenda's Drug Patent Language

Editor's pick
TheBody
18 July 2021
PrEP programmes & uptake

US: ‘This will shut us down’: HIV prevention clinics brace for Gilead reimbursement cuts

Editor's pick
NBC News
8 July 2021
Pharmaceutical industry

Gilead files long-acting HIV med for patients running out of options

Editor's pick
FierceBiotech
1 July 2021
Pharmaceutical industry

GSK puts long-acting injectables at heart of HIV growth plans, downplays threat of oral rival from Gilead and Merck

Editor's pick
FiercePharma
29 June 2021
New & experimental HIV treatments

Gilead Submits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options

Editor's pick
Gilead press release
29 June 2021
Injectable & long-acting HIV treatment

GSK's ViiV, under threat from Gilead-Merck collab, eyes 'ultra-long-acting' HIV drugs with Halozyme deal

Editor's pick
FiercePharma
23 June 2021
Injectable & long-acting HIV treatment

Long-acting Injectables: when will they be available in the UK?

Editor's pick
UK-CAB
21 June 2021
Pharmaceutical industry

Intentionally Delayed Pharmaceutical Innovation Under Perverse Incentives: Gilead's HIV Pipeline As A Case Study

Editor's pick
Health Affairs
17 June 2021
The search for a cure

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure

Editor's pick
GlobeNewswire
16 June 2021
Government, leadership & policy

MSF: The 4th UN Declaration on AIDS a disappointing step in the fight against HIV/AIDS

Editor's pick
MSF
11 June 2021